Teleflex

Yahoo Finance • 3 days ago

Myriad Genetics, Omnicell, Globus Medical, Repligen, and Teleflex Stocks Trade Down, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. The president's tone and the suggestion of canceling... Full story

Yahoo Finance • 3 days ago

Palm Valley Capital Fund takes new stakes in TFX, RHI, LKQ and AVA

Palm Valley Capital Fund increased 2.35%, trailing the 9.11% gain for the S&P SmallCap 600 and 7.99% increase for the Morningstar Small Cap Total Return index during the quarter, . The fund acquired four positions during the third quarte... Full story

Yahoo Finance • 5 days ago

What Makes Teleflex (TFX) an Investment Choice?

Palm Valley Capital Management, an investment management firm, has released the “Palm Valley Capital Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. In the third quarter, Palm Valley Capital Fund appr... Full story

Yahoo Finance • 14 days ago

Vanguard Health Care ETF -- Insider Buying Index Registering 19.8%

A look at the weighted underlying holdings of the Vanguard Health Care ETF (Symbol: VHT) shows an impressive 19.8% of holdings on a weighted basis have experienced insider buying within the past six months. Teleflex Incorporated (Symbol:... Full story

Yahoo Finance • 18 days ago

Thursday's ETF Movers: REMX, FXH

In trading on Thursday, the VanEck Rare Earth/Strategic Metals ETF is outperforming other ETFs, up about 3.2% on the day. Components of that ETF showing particular strength include shares of Lithium Americas, up about 17% and shares of Li... Full story

Yahoo Finance • 27 days ago

Teleflex Incorporated (TFX) Plans 2026 Split into Two Independent Companies

In this article, we will be taking a look at the 12 Cheap Healthcare Stocks to Buy Now. Teleflex Incorporated is one of them. Teleflex Incorporated (NYSE:TFX) tops our list for being one of the cheap healthcare stocks. It is a global medi... Full story

Yahoo Finance • last month

First Patient Enrolled in DUBSTENT DIABETES Trial: Targeting Improved PCI Outcomes for Diabetic Patients

WAYNE, Pa., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the enrollment of the first patient in the DUBSTENT DIABETES trial. The randomized, inves... Full story

Yahoo Finance • 2 months ago

Teleflex to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

WAYNE, Pa., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Management of Teleflex Incorporated (NYSE: TFX) will be presenting at the Morgan Stanley 23rd Annual Global Healthcare Conference at the Sheraton New York Times Square, on Tuesday, September... Full story

Yahoo Finance • 2 months ago

Teleflex Inc. (NYSE:TFX) Emerges as a Top Value Stock with Strong Fundamentals

In value investing, the search for undervalued stocks is a central strategy, built on ideas from Benjamin Graham and developed further by investors like Warren Buffett. This method finds companies trading for less than their inherent worth... Full story

Yahoo Finance • 2 months ago

What Teleflex (TFX)'s Barrigel Launch in Japan Means for Shareholders

Teleflex Incorporated recently announced that its Barrigel rectal spacer is now available for purchase in Japan, following regulatory approval, insurance coverage acceptance, and issuance of appropriate use criteria by Japanese academic so... Full story

Yahoo Finance • 2 months ago

Teleflex launches Barrigel rectal spacer for prostate radiation in Japan

WAYNE, Pa. - Teleflex Incorporated (NYSE:TFX), a medical technology company with annual revenues of $3.04 billion, announced Tuesday that its Barrigel rectal spacer is now available in Japan following regulatory approval from the Japanese... Full story

Yahoo Finance • 2 months ago

Teleflex Announces the Launch of Barrigel™ Rectal Spacer in Japan as a Proven Safe and Effective Option to Minimize the Harmful Long-Term Side Effects of Prostate Radiation Therapy

Innovative hyaluronic acid technology delivers enhanced control and precision, significantly lowering the risk of rectal toxicity during prostate radiation treatment.1-4 Initial cases have now been performed in Japan. WAYNE, Pa., Aug.... Full story

Yahoo Finance • 2 months ago

Ex-Dividend Reminder: Eli Lilly, Teleflex and Royalty Pharma

Looking at the universe of stocks we cover at Dividend Channel, on 8/15/25, Eli Lilly (Symbol: LLY), Teleflex Incorporated (Symbol: TFX), and Royalty Pharma plc (Symbol: RPRX) will all trade ex-dividend for their respective upcoming divide... Full story

Yahoo Finance • 2 months ago

Moderna, Teleflex, Envista, Enovis, and UnitedHealth Shares Are Soaring, What You Need To Know

What Happened? A number of stocks jumped in the morning session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed inflation rose by a modest 0.2... Full story

Yahoo Finance • 2 months ago

[Latest] Global High Flow Nasal Cannula Market Size/Share Worth USD 5.9 Billion by 2034 at a 5.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global High Flow Nasal Cannula Market size & share revenue was valued at approximately USD... Full story

Yahoo Finance • 2 months ago

Teleflex Inc (NYSE:TFX) Recognized as a Strong Value Investment with Solid Fundamentals

Teleflex Inc (NYSE:TFX [https://www.chartmill.com/stock/quote/TFX]) has been recognized by a "Decent Value" screening method, which finds stocks with good fundamental valuations while keeping reasonable profitability, financial stability,... Full story

Yahoo Finance • 2 months ago

Teleflex Second Quarter 2025 Earnings: Beats Expectations

Teleflex (NYSE:TFX) Second Quarter 2025 Results Key Financial Results Revenue: US$780.9m (up 4.2% from 2Q 2024). Net income: US$122.6m (up 53% from 2Q 2024). Profit margin: 16% (up from 11% in 2Q 2024). EPS: US$2.77 (up from US$1.70 in 2... Full story

Yahoo Finance • 2 months ago

Teleflex stock price target raised to $135 from $130 at RBC Capital

Investing.com - RBC Capital has raised its price target on Teleflex (NYSE:TFX) to $135.00 from $130.00 while maintaining a Sector Perform rating on the medical device company. According to InvestingPro analysis, Teleflex currently trades a... Full story

Yahoo Finance • 2 months ago

Teleflex Inc (NYSE:TFX) Beats Q2 2025 Earnings Estimates with Strong Revenue and EPS Growth

Teleflex Incorporated (NYSE:TFX [https://www.chartmill.com/stock/quote/TFX/profile]) reported its second-quarter financial results for 2025, delivering revenue and earnings per share (EPS) that exceeded analyst expectations. The medical te... Full story

Yahoo Finance • 2 months ago

Teleflex Boosts FY25 Outlook, Declares Dividend - Update

(RTTNews) - While reporting financial results for the second quarter on Thursday, specialty medical devices provider Teleflex, Inc. (TFX) raised its earnings, adjusted earnings and revenue guidance for the full-year 2025. For fiscal 2025,... Full story